Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Deep Vein Arterialization Post-Market Study

NCT03807661 is registered in ClinicalTrials.gov with LimFlow SA as lead sponsor.

NCT NCT03807661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Deep Vein Arterialization Post-Market Study
Lead sponsor
LimFlow SA
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2019
Completion date
October 28, 2024
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia